As of 30 Sep 2025, 21 institutional investors reported holding $345,063,000 in principal (par value) of NEOGENOMICS INC - NOTE 0.250% 1/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $11,000 | $985,000 | 8954.55% | 1 | |
| 2025 Q3 | $345,063,000 | $300,247,353 | -$1,049,875 | 86.5% | 21 |
| 2025 Q2 | $347,424,500 | $298,701,017 | +$1,331,189 | 85.38% | 24 |
| 2025 Q1 | $345,968,500 | $300,355,491 | +$507,062 | 86.32% | 24 |
| 2024 Q4 | $346,156,500 | $292,693,576 | -$7,990,579 | 84.0% | 27 |
| 2024 Q3 | $356,060,500 | $296,374,809 | +$17,436,991 | 82.86% | 28 |
| 2024 Q2 | $335,580,500 | $263,497,853 | +$1,307,266 | 78.17% | 28 |
| 2024 Q1 | $333,774,500 | $266,976,883 | +$1,456,914 | 79.75% | 25 |
| 2023 Q4 | $333,400,500 | $253,694,490 | +$1,078,650 | 75.61% | 30 |
| 2023 Q3 | $329,987,000 | $237,042,149 | -$556,397 | 71.53% | 28 |
| 2023 Q2 | $330,413,000 | $243,310,561 | +$1,542,843 | 73.33% | 32 |
| 2023 Q1 | $330,802,000 | $244,200,293 | +$1,968,980 | 73.52% | 30 |
| 2022 Q4 | $331,648,000 | $216,325,355 | +$776,516 | 64.63% | 34 |
| 2022 Q3 | $277,556,500 | $181,376,487 | -$23,788,181 | 64.64% | 31 |
| 2022 Q2 | $322,240,862 | $198,764,695 | +$15,419,191 | 62.13% | 31 |
| 2022 Q1 | $298,622,736 | $195,443,373 | -$3,657,229 | 66.5% | 35 |
| 2021 Q4 | $293,173,500 | $244,456,981 | -$16,959,876 | 85.41% | 30 |
| 2021 Q3 | $320,409,500 | $323,678,284 | +$7,689,047 | 101.13% | 34 |
| 2021 Q2 | $308,929,774 | $306,225,832 | +$982,880 | 97.62% | 30 |
| 2021 Q1 | $299,028,440 | $316,018,032 | +$316,017,674 | 101.12% | 39 |